DOHA: Chief Executive Officer (CEO) of Sidra Medicine — member of Qatar Foundation (QF) — Peter Morris said that Sidra’s vision is to become a beacon of learning, discovery and exceptional care.
Commenting on the grand opening of Sidra Medicine, Peter Morris, said: “Under the leadership of H H Sheikha Moza bint Nasser the Chairperson of Qatar Foundation we’ve made incredible progress in a short space of time and laid strong foundations for our future success. At Sidra Medicine, we have globally competitive clinicians and scientists working together on a single campus with state of the art equipment and technology in a stunning new hospital.”
One of the most ambitious greenfield hospital developments of its kind, Sidra Medicine represents the vision of Her Highness Sheikha Moza bint Nasser to develop the region’s leading academic medical center and provide healthcare of the highest global standards to the people of Qatar and beyond.
The new hospital addresses the growing need for specialist children’s and maternity care by offering services previously unavailable in Qatar and, in many cases, across the wider MENA region.
The ultra-modern, high-tech facility is situated in a striking building designed by renowned architect Pelli Clarke. More than 4,000 highly-trained clinical and support staff representing over 85 nationalities have been drawn by Sidra Medicine’s ambitious vision to care for women, children, and young people.
The new hospital provides more than 50 services across outpatient clinics and to inpatients, with 400 new beds across three hospital wings. With access to leading technology ranging from intra-operative MRIs and robotic-assisted surgical systems, experts at Sidra Medicine focus on treating a range of highly-complex and challenging conditions.
Some of the children’s specialist services available at Sidra Medicine include cardiology, neurology, urology, and plastics and craniofacial reconstruction surgery. The hospital has brought together some of the world’s leading practitioners and pioneers in these fields. Along with highly-qualified multi-disciplinary teams, they provide the very best in specialized care to women and children.
Sidra Medicine takes a multidisciplinary approach to patient care, where a group of dedicated clinical and support staff sees one patient throughout their journey with Sidra Medicine. The teams are made up of physicians who work with nurses, nurse practitioners, dieticians, mental health experts, child life specialists and many other experts, depending on the patient’s individual needs.
Sidra Medicine is focusing considerable resources on developing biomedical and clinical research capable of improving patient outcomes. These include a collaboration with the Qatar Genome Programme, a member of QF, which is an ambitious population-based project designed to generate genome sequencing and molecular data about the Qatari population, and link it to a national electronic medical record system to chart a roadmap for future advanced healthcare through personalized medicine.
Among its many other research priorities, Sidra Medicine is gathering detailed epidemiological data to understand the biochemical and molecular diagnosis of childhood diabetes in Qatar. Efforts to build an accurate bank of data showing the causes of diabetes for the entire pediatric population are underway, with the aim of tailoring treatment for each child at Sidra Medicine.
In addition to delivering outstanding care and undertaking leading research, Sidra Medicine is building capacity and expertise in Qatar’s healthcare system through a clear and comprehensive commitment to the highest standards of medical education and continuous professional development opportunities for healthcare professionals. Along with a development strategy tailored for national talent, Sidra Medicine is also offering medical trainees an exceptional educational experience to develop safe and competent doctors specialized in children’s and women’s health.
